1
Department of Pharmacology and Therapeutics, University of
Liverpool, Liverpool, UK
2
Department of Infectious Diseases, University Hospital of Wales, Cardiff and
Vale University Health Board, UK
3
Department of Intensive Care, University College London Hospital, ULCH NHS
Trust, London, UK
4
Department of Infectious Diseases, Chelsea and Westminster Hospital, Imperial
NHS Trust, London, UK
5
Faculty of Medicine, Imperial College London,
London, UK
6
Oxford University Clinical Academic Graduate School, University of
Oxford, Oxford, UK
✉Correspondence: Andrew Hill, PhD, Department of Pharmacology and
Therapeutics, University of Liverpool, 70 Pembroke Place, Liverpool L69 3GF, UK (microhaart@aol.com).
© The Author(s) 2021. Published by Oxford University Press on behalf of
Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits
non-commercial reproduction and distribution of the work, in any medium, provided the
original work is not altered or transformed in any way, and that the work is properly
cited. For commercial re-use, please contact journals.permissions@oup.com
